Adrien Cohen
Associate @ Creative Destruction Lab
London, United Kingdom
Adrien Cohen is a venture - series unknown investor at Creative Destruction Lab in London focused on Medical and Battery. Adrien Cohen is the President and Co-Founder of Tractable. He attended HEC Paris and Tsinghua University.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Adrien Cohen invests in
Stages Adrien Cohen invests in
Countries Adrien Cohen invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 2 (50%)
- Battery 1 (25%)
- Software 1 (25%)
- Biopharma 1 (25%)
- Automotive 1 (25%)
Stage
- Venture - Series Unknown 3 (75%)
- Seed 1 (25%)
Country
- United Kingdom 3 (75%)
- United States 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ViaNautis
|
Precision Solutions | $23.3M / Venture - Series Unknown / Sep 09, 2026 | |
Precision Neuroscience
|
Precision Neuroscience is a neural platform for next-generation brain-computer interface technology. The company's goal is to provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses. Its brain–computer interface is designed to be minimally invasive, safely removable, and capable ofprocessing large amounts of data.The company was founded in 2021 and is based in New York. | Venture - Series Unknown / Nov 05, 2025 | |
Healx
|
Healx is a mission-driven technology company pioneering the next wave of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are 7,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AItechnology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this huge unmet need and have unprecedented patient impact. Founded in Cambridge, UK, in 2014 by Dr Tim Guilliams (a Biochemical Engineer and tech entrepreneur) and Dr David Brown (co-inventor of Viagra and former Global Head of Drug Discovery at Roche), Healx has raised $70 million to date. For more information, visit www.healx.io. | Venture - Series Unknown / Jul 01, 2025 | |
Breathe Battery Technologies
|
Physics-based adaptive charging for software-defined batteries. We help the world’s leading automotive and consumer electronics brands deliver superior charging experiences. Our dream is that one day everyone will breathe clean air. That's why we make batteries better. | $2M / Seed / Dec 02, 2021 |
Co-Investors
4BIO Capital
1 deal together
Speedinvest
1 deal together
UCB Ventures
1 deal together
About Creative Destruction Lab
Creative Destruction Lab (CDL) is a no-fee/no-equity organization that delivers an objectives-based mentoring program for massively scalable, pre-seed stage, science- and technology-based companies. Its nine-month program allows founders to learn from experienced entrepreneurs, increasing their likelihood of success. Founded in 2012 byProfessor Ajay Agrawal at the University of Toronto’s Rotman School of Management, the program has expanded to thirteen sites across seven countries: Seattle, Oxford, Paris, Atlanta, Estonia, Wisconsin, Vancouver, Calgary, Montreal, Berlin, Melbourne and Halifax.
Creative Destruction Lab Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Anthony K. Tjan
Fellow
|
|||
Daniel Mulet Lind
Associate Director, Quantum Machine Learning
|
|||
Dennis Bennie
Founding Partner and Associate
|
|||
Dennis Kavelman
Founding Partner and Associate
|
|||
Frank Sobey
Founding Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Adrien Cohen invest in?
Adrien Cohen invests primarily in Medical, Battery and Software startups, most often at Venture - Series Unknown and Seed stage. Most of the 4 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Adrien Cohen?
Public channels for Adrien Cohen include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Adrien Cohen last invest?
The most recent investment recorded for Adrien Cohen closed in Sep 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
